< Back to latest news & events

Event

IAM webinar: How to capitalise on the 5G healthcare revolution

April 2021

Event date: 25th May 2021

HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May.

This session will explore how 5G wireless technology will revolutionise the healthcare industry. 5G is promising greater bandwidth, faster speeds and lower latency, and with that, to transform industries including healthcare. Virtual patient care, remote robotic surgery and sharing of 3D medical images for diagnosis of specialists located anywhere across the globe are a few examples of transformative changes to come. 5G will not only enable new healthcare services but also improve the workflow of hospitals and healthcare professionals as they evolve from using wired networks to mobile networks. 5G is also considered to expand the wearables market further as wearables will be able to send and receive far greater amounts of data wirelessly than with 4G, providing the wearers and doctors with real-time monitoring data in volumes that will allow much more powerful insight into an individual’s health status. This session will also explore challenges of 5G in the healthcare industry including how to recognise patentable aspects of 5G implementation in the healthcare sector, data security aspects, and how patent owners of 5G technology can license patents for their technology in vertical markets such as wearables.

Join Dr Susan Keston and Dr Sofie McPherson to find out more on this topic on Tuesday 25th May 2021.

Latest updates

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Enlarged Board of Appeal has today issued its decision in seminal case G1/24

G1/24, described as one of the most important cases in decades, relates to how claims of patents are to be interpreted by the Boards of Appeal and, by extension, all …

Read article

UPC’s Hamburg Local Division provides guidance on the extent to which a patent may be used as its own “lexicon”

Agfa NV v Gucci & Anors. [UPC_CFI_278/2023] – Hamburg Local Division of the UPC (Klepsch, Schilling, Sarlin) – 30 April 2025 While we await a decision on G1/24 from the …

Read article

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article

Agritech Thymes: Agritech 2030: Forecasting the Technologies Poised to Transform Farming

Whilst yet to recover to the levels of 2011-2021, where capital invested in agritech increased 20-fold, investor funding in agritech is starting to pick up, and 2025 is set to …

Read article

UPC delivers first judgment on Validity and Infringement of a Second Medical Use Claim

Sanofi Biotechnology SAS & Anor v Amgen, Inc., & Ors– Thomas, Thom, Kupecz and Dorland-Galliot – [UPC_CFI_505/2024] The Dusseldorf Local Division (LD) has delivered the UPC’s first Judgment on second …

Read article